Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CryoCor CryoBlator

This article was originally published in The Gray Sheet

Executive Summary

Cardiac cryoablation catheter system gains full IDE trial clearance to treat atrial flutter and atrial fibrillation in a U.S. study. Previously named the CryoCor Model 1200, the device has been CE-marked in Europe since December 2003. The firm expects to submit a PMA by the end of 2006 (1"The Gray Sheet" July 5, 2004, In Brief)...

You may also be interested in...

Whither atrial fibrillation ablation

FDA grants conditional IDE approval for a proposed atrial fibrillation clinical trial of the CryoCor cardiac cryoablaton system. The San Diego firm expects to complete enrollment by the end of 2005 and submit a PMA for the system by the end of 2006...

US FDA Not Changing Assessment Goals Because of Coronavirus-Mandated Telework

Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts